ARGS

Argos Therapeutics, Inc.
ARGS

Overview Fund Activity
Delisted

ARGS was delisted on the 24th of April, 2018.

Back to rankings

26 hedge funds and large institutions have $39.1M invested in Argos Therapeutics, Inc. in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
–
Holders Change %
0%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WA
1
Wasatch Advisors
Utah
$14.6M
2
CS
2
Credit Suisse
Switzerland
$415K
3
BCM
3
Bridgeway Capital Management
Texas
$400K
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$1.01M
5
Northern Trust
5
Northern Trust
Illinois
$117K

Top Sellers

1
Caisse de Depot et Placement du Quebec (CDPQ)
1
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$3.88M
2
SKK
2
Shepherd Kaplan Krochuk
Massachusetts
$0
3
AGA
3
Altrinsic Global Advisors
Connecticut
$2.37M
4
KeyBank National Association
4
KeyBank National Association
Ohio
$149K
5
Bank of America
5
Bank of America
North Carolina
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
AIG
26
American International Group
New York
$660 -$1.54K -7 -70%
SKK
27
Shepherd Kaplan Krochuk
Massachusetts
– -$228K -1,135 Closed
Bank of America
28
Bank of America
North Carolina
– -$20K -100 Closed
BNP Paribas Financial Markets
29
BNP Paribas Financial Markets
France
– -$3.67K -18 Closed
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$3 -13 Closed
Barclays
31
Barclays
United Kingdom
– -$1K -3 Closed
1
2